These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1224 related articles for article (PubMed ID: 3733527)

  • 1. Elsamicins, new antitumor antibiotics related to chartreusin. I. Production, isolation, characterization and antitumor activity.
    Konishi M; Sugawara K; Kofu F; Nishiyama Y; Tomita K; Miyaki T; Kawaguchi H
    J Antibiot (Tokyo); 1986 Jun; 39(6):784-91. PubMed ID: 3733527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new antitumor antibiotic product, demethylchartreusin. Isolation and biological activities.
    Aoyama Y; Katayama T; Yamamoto M; Tanaka H; Kon K
    J Antibiot (Tokyo); 1992 Jun; 45(6):875-8. PubMed ID: 1500353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chartreusin, elsamicin A and related anti-cancer antibiotics.
    Portugal J
    Curr Med Chem Anticancer Agents; 2003 Nov; 3(6):411-20. PubMed ID: 14529449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chrymutasins: novel-aglycone antitumor antibiotics from a mutant of Streptomyces chartreusis. I. Taxonomy, mutation, fermentation, isolation and biological activities.
    Uchida H; Nakakita Y; Enoki N; Abe N; Nakamura T; Munekata M
    J Antibiot (Tokyo); 1994 Jun; 47(6):648-54. PubMed ID: 8040069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antitumor activity of analogues of the antitumor antibiotic chartreusin.
    Takai M; Uehara Y; Beisler JA
    J Med Chem; 1980 May; 23(5):549-53. PubMed ID: 7381855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and cytostatic activity of the antitumor antibiotic chartreusin derivatives.
    Kon K; Sugi H; Tamai K; Ueda Y; Yamada N
    J Antibiot (Tokyo); 1990 Apr; 43(4):372-82. PubMed ID: 2351612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective DNA cleavage by elsamicin A and switch function of its amino sugar group.
    Uesugi M; Sekida T; Matsuki S; Sugiura Y
    Biochemistry; 1991 Jul; 30(27):6711-5. PubMed ID: 1648389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of terpentecin, a new antitumor antibiotic.
    Tamamura T; Sawa T; Isshiki K; Masuda T; Homma Y; Inuma H; Naganawa H; Hamada M; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1985 Dec; 38(12):1664-9. PubMed ID: 3841535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kedarcidin, a new chromoprotein antitumor antibiotic. I. Taxonomy of producing organism, fermentation and biological activity.
    Lam KS; Hesler GA; Gustavson DR; Crosswell AR; Veitch JM; Forenza S; Tomita K
    J Antibiot (Tokyo); 1991 May; 44(5):472-8. PubMed ID: 2061190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrocarcins, novel antitumor antibiotics. II. Isolation, characterization and antitumor activity.
    Tamaoki T; Kasai M; Shirahata K; Ohkubo S; Morimoto M; Mineura K; Ishii S; Tomita F
    J Antibiot (Tokyo); 1980 Sep; 33(9):946-50. PubMed ID: 6160139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gilvocarcins, new antitumor antibiotics. 1. Taxonomy, fermentation, isolation and biological activities.
    Nakano H; Matsuda Y; Ito K; Ohkubo S; Morimoto M; Tomita F
    J Antibiot (Tokyo); 1981 Mar; 34(3):266-70. PubMed ID: 7275807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BBM-928, a new antitumor antibiotic complex. I. Production, isolation, characterization and antitumor activity.
    Ohkuma H; Sakai F; Nishiyama Y; Ohbayashi M; Imanishi H; Konishi M; Miyaki T; Koshiyama H; Kawaguchi H
    J Antibiot (Tokyo); 1980 Oct; 33(10):1087-97. PubMed ID: 7451357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production, isolation and structure determination of novel fluoroindolocarbazoles from Saccharothrix aerocolonigenes ATCC 39243.
    Lam KS; Schroeder DR; Veitch JM; Colson KL; Matson JA; Rose WC; Doyle TW; Forenza S
    J Antibiot (Tokyo); 2001 Jan; 54(1):1-9. PubMed ID: 11269705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and biological activity of rebeccamycin, a novel antitumor agent.
    Bush JA; Long BH; Catino JJ; Bradner WT; Tomita K
    J Antibiot (Tokyo); 1987 May; 40(5):668-78. PubMed ID: 3112080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elsamicin A binding to DNA. A comparative thermodynamic characterization.
    Barceló F; Portugal J
    FEBS Lett; 2004 Oct; 576(1-2):68-72. PubMed ID: 15474012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Map of chartreusin and elsamicin binding sites on DNA.
    Salas X; Portugal J
    FEBS Lett; 1991 Nov; 292(1-2):223-8. PubMed ID: 1959610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WF-3405, a novel antitumor antibiotic. Taxonomy, isolation, structure elucidation and biological properties.
    Kiyoto S; Murai H; Tsurumi Y; Terano H; Kohsaka M; Takase S; Uchida I; Hashimoto M; Aoki H; Imanaka H
    J Antibiot (Tokyo); 1987 Mar; 40(3):290-5. PubMed ID: 3570981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switch-function of amino sugar on elsamicin A, a DNA binding antitumor antibiotic.
    Uesugi M; Sugiura Y
    Nucleic Acids Symp Ser; 1990; (22):33-4. PubMed ID: 2101907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMY-28438 (3,7-dihydroxytropolone), a new antitumor antibiotic active against B16 melanoma. I. Production, isolation, structure and biological activity.
    Sugawara K; Ohbayashi M; Shimizu K; Hatori M; Kamei H; Konishi M; Oki T; Kawaguchi H
    J Antibiot (Tokyo); 1988 Jul; 41(7):862-8. PubMed ID: 3417559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luminamicin, a new antibiotic. Production, isolation and physico-chemical and biological properties.
    Omura S; Iwata R; Iwai Y; Taga S; Tanaka Y; Tomoda H
    J Antibiot (Tokyo); 1985 Oct; 38(10):1322-6. PubMed ID: 3840790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.